Kenvue Inc. (KVUE) to Issue Quarterly Dividend of $0.21 on February 25th

Kenvue Inc. (NYSE:KVUE) announced a quarterly dividend on Wednesday, January 28th. Shareholders of record on Wednesday, February 11th will be given a dividend of 0.2075 per share on Wednesday, February 25th. This represents a c) annualized dividend and a dividend yield of 4.8%. The ex-dividend date of this dividend is Wednesday, February 11th.

Kenvue has a dividend payout ratio of 68.0% meaning its dividend is sufficiently covered by earnings. Analysts expect Kenvue to earn $1.24 per share next year, which means the company should continue to be able to cover its $0.83 annual dividend with an expected future payout ratio of 66.9%.

Kenvue Trading Down 0.9%

Kenvue stock opened at $17.19 on Friday. Kenvue has a one year low of $14.02 and a one year high of $25.17. The company has a market cap of $32.93 billion, a price-to-earnings ratio of 22.91 and a beta of 0.60. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.69. The firm has a 50-day moving average of $17.15 and a 200-day moving average of $18.07.

Kenvue (NYSE:KVUE) last posted its earnings results on Monday, November 3rd. The company reported $0.28 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The business had revenue of $3.76 billion for the quarter, compared to analyst estimates of $3.83 billion. During the same period in the previous year, the firm earned $0.28 EPS. The firm’s revenue was down 3.5% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, equities analysts expect that Kenvue will post 1.14 earnings per share for the current fiscal year.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.